Tag: what does the hormone glucagon do

Glucagon in Peptide Therapeutics: Market Trends, Brand Comparisons, and Mechanism of Action

Abstract: Glucagon, a 29-amino acid peptide hormone, counteracts hypoglycemia by stimulating hepatic glycogenolysis and gluconeogenesis. In peptide therapeutics, its market is expanding due to novel formulations (e.g., nasal, injectable) for severe hypoglycemia. Brand comparisons (e.g., GlucaGen vs. Baqsimi) highlight differences in stability, delivery, and patient compliance. Current industry trends favor ready-to-use devices over lyophilized powders, with strict FDA/EMA certifications ensuring safety. Key selection criteria include purity (>98%), cold-chain logistics, and manufacturer GMP compliance. The sector shows robust growth driven by diabetes prevalence and biosimilar innovations.